RxDoctor Payments Data

Amanda Currier, NP

Acute Care · Derry, NHNPI 1902394620

Payments from drug & device makers

What this record shows

Amgen accounts for 86.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $885 and has fallen 97.7% since, to $21 in 2025.

$1,185in general payments, 2019–2025

Across 24 payments — averaging $49.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Biogen$105
  • Lilly USA, LLC$21
  • AstraZeneca$21
  • Genentech USA, Inc.$17

What the payments were for

  • Speaking & faculty fees$56047%
  • Food & beverage$62553%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)19$1,021
Biogen2$105
Lilly USA, LLC1$21
AstraZeneca1$21
Genentech USA, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,185 in reported general payments places this provider in the 85th percentile of 44 acute care providers in New Hampshire.

See all acute care providers in New Hampshire

Medicare billing

Part B allowed, 2024
$3,717,149
Medicare patients
207
Services billed
102,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Derry

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →